title: [Outpatient alcohol detoxification].
abstract: Increasing significance is being attributed to outpatient detoxification treatment of alcohol-dependent patients. Many patients want to undergo outpatient detoxification or even carry it out without professional supervision. In some Scandinavian countries and in the USA, outpatient detoxification under medical supervision has increased substantially. In these countries,numerous studies describe outpatient alcohol detoxification as a safe and cost-reducing method. These studies vary in many aspects, especially regarding the nature and dose of the withdrawal medication, but also concerning the inclusion criteria of patients. Medications to treat or prevent alcohol withdrawal symptoms are rather heterogeneous. Besides well-known standard medication established in inpatient treatment (e.g.,benzodiazepines and carbamazepine), interesting studies report the application of rather uncommon substances such as physostigmine and psychotropic analgesic nitrous oxide (PAN) for alcohol detoxification. This article provides an overview on outpatient alcohol detoxification and discusses its transfer to practical application.
authors.affiliation: Klinik für Abhängiges Verhalten und Suchtmedizin,Zentralinstitut für Seelische Gesundheit, Mannheim.
authors.forename: T
authors.initials: T
authors.lastname: Scherle
authors.forename: B
authors.initials: B
authors.lastname: Croissant
authors.forename: A
authors.initials: A
authors.lastname: Heinz
authors.forename: K
authors.initials: K
authors.lastname: Mann
mesh_terms: D000427:Alcohol Deterrents / Q000627:therapeutic use; D000437:Alcoholism / Q000534:rehabilitation*; D000553:Ambulatory Care; D000431:Ethanol / Q000009:adverse effects; D005858:Germany; D006801:Humans; D011619:Psychotropic Drugs / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000534:rehabilitation; D016896:Treatment Outcome
chemical_list: D000427:Alcohol Deterrents; D011619:Psychotropic Drugs; D000431:Ethanol